HTG MOLECULAR DIAGNOSTICS, INC (41) | Sales Agreements (2)
- Controlled Equity OfferingSM Sales Agreement, dated as of November 14, 2019, by and between HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 15, 2019)
- Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)
